9 Meters Biopharma Inc. (NMTR) NASDAQ
$0.07 - (-)
Market Cap: -
As of 07/25/23 12:00 AM EDT. Market closed.
9 Meters Biopharma Inc. (NMTR)
NASDAQ
$0.07
- (-)
Market Cap: -
As of 07/25/23 12:00 AM EDT. Market closed.
9 meters biopharma, inc., a clinical-stage biotechnology company, focuses on patients with rare disorders and unmet needs. the company's pipeline includes drug candidates for short bowel syndrome (sbs) and celiac disease. it is developing nm-002, a long-acting injectable glp-1 agonist that is in a phase 2 clinical trial for sbs; and larazotide, a phase 3-stage therapeutic in development for ... read more
9 meters biopharma, inc., a clinical-stage biotechnology company, focuses on patients with rare disorders and unmet needs. the company's pipeline includes drug candidates for short bowel syndrome (sbs) and celiac disease. it is developing nm-002, a long-acting injectable glp-1 agonist that is in a phase 2 clinical trial for sbs; and larazotide, a phase 3-stage therapeutic in development for celiac disease. the company also develops nm-003, a proprietary long-acting glp-2 agonist; and nm-004, a double-cleaved mesalamine with an immunomodulator for developing rare and/or orphan indications. 9 meters biopharma, inc. is based in raleigh, north carolina. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Sensenig Bethany | Chief Financial Officer | Apr 21, 2023 | Sale | $1.21 | 9,100 | 11,011 | 41,077 | Apr 21, 2023, 05:08 PM |
Sirgo Mark A | Director | Jul 01, 2022 | Option Exercise | $0.25 | 175,000 | 42,962 | 1,560,428 | Jul 22, 2022, 04:21 PM |
Temperato John | Chief Executive Officer | Jul 06, 2022 | Buy | $0.23 | 125,000 | 28,462 | 1,427,522 | Jul 08, 2022, 08:01 AM |
Sirgo Mark A | Director | Jul 01, 2022 | Buy | $0.25 | 175,000 | 42,962 | 1,454,045 | Jul 06, 2022, 04:43 PM |
Constantino Michael T. | Director | May 23, 2022 | Buy | $0.48 | 16,000 | 7,608 | 60,509 | May 24, 2022, 04:01 PM |
Temperato John | Chief Executive Officer | May 18, 2022 | Buy | $0.45 | 50,000 | 22,285 | 1,302,522 | May 19, 2022, 04:09 PM |
Sirgo Mark A | Director | May 18, 2022 | Buy | $0.47 | 106,383 | 50,000 | 1,385,428 | May 19, 2022, 04:01 PM |
Constantino Michael T. | Director | Aug 20, 2020 | Buy | $0.75 | 26,509 | 20,001 | 26,509 | Mar 21, 2022, 04:17 PM |
Sirgo Mark A | Director | Mar 03, 2022 | Buy | $0.58 | 86,450 | 50,003 | 1,279,045 | Mar 07, 2022, 08:01 AM |
Temperato John | Chief Executive Officer | Mar 03, 2022 | Buy | $0.56 | 100,000 | 55,590 | 1,252,522 | Mar 04, 2022, 08:00 AM |
Sirgo Mark A | Director | Dec 02, 2021 | Buy | $0.89 | 50,000 | 44,500 | 1,242,595 | Dec 03, 2021, 07:34 AM |
Sirgo Mark A | Director | Nov 18, 2021 | Buy | $1.06 | 20,000 | 21,200 | 1,192,595 | Nov 22, 2021, 07:30 AM |
Temperato John | Chief Executive Officer | Nov 18, 2021 | Buy | $1.05 | 50,000 | 52,500 | 1,152,522 | Nov 19, 2021, 07:31 AM |
Sitar Edward J | Chief Financial Officer | Sep 14, 2021 | Buy | $1.22 | 15,000 | 18,300 | 194,338 | Sep 15, 2021, 08:12 AM |
Sirgo Mark A | Director | Sep 07, 2021 | Buy | $1.36 | 73,529 | 99,999 | 1,172,595 | Sep 08, 2021, 08:15 AM |
Constantino Michael T. | Director | Aug 24, 2021 | Buy | $1.14 | 18,000 | 20,520 | 52,108 | Aug 26, 2021, 08:18 AM |
Sirgo Mark A | Director | Aug 20, 2021 | Buy | $1.10 | 25,000 | 27,500 | 1,099,066 | Aug 23, 2021, 08:15 AM |
Temperato John | Chief Executive Officer | Aug 18, 2021 | Buy | $1.05 | 25,000 | 26,250 | 1,102,522 | Aug 19, 2021, 08:16 AM |
OrbiMed Israel GP Ltd. | 10% Owner | Jun 25, 2021 | Sale | $1.21 | 15,989,876 | 19,347,751 | 8,565,974 | Jun 25, 2021, 07:08 PM |
OrbiMed Israel GP Ltd. | 10% Owner | Jun 24, 2021 | Sale | $1.38 | 319,255 | 440,572 | 24,555,850 | Jun 25, 2021, 07:08 PM |
OrbiMed Israel GP Ltd. | 10% Owner | Jun 23, 2021 | Sale | $1.36 | 841,650 | 1,144,644 | 24,875,105 | Jun 25, 2021, 07:08 PM |
Temperato John | Chief Executive Officer | Dec 15, 2020 | Buy | $0.65 | 153,846 | 100,000 | 977,522 | Dec 17, 2020, 04:17 PM |
Sirgo Mark A | Director | Dec 15, 2020 | Buy | $0.65 | 230,769 | 150,000 | 774,066 | Dec 17, 2020, 04:17 PM |
Sitar Edward J | Chief Financial Officer | Dec 15, 2020 | Buy | $0.65 | 61,538 | 40,000 | 129,338 | Dec 17, 2020, 04:17 PM |
Sirgo Mark A | Director | Sep 11, 2020 | Buy | $0.65 | 21,485 | 14,004 | 21,485 | Sep 14, 2020, 08:06 AM |
Sirgo Mark A | Director | Sep 11, 2020 | Buy | $0.68 | 77,000 | 52,360 | 538,784 | Sep 14, 2020, 08:06 AM |
Sirgo Mark A | Director | Sep 10, 2020 | Buy | $0.60 | 50,000 | 30,000 | 461,784 | Sep 14, 2020, 08:06 AM |
Temperato John | Chief Executive Officer | Aug 21, 2020 | Buy | $0.69 | 70,000 | 48,300 | 615,496 | Aug 24, 2020, 07:01 AM |
Constantino Michael T. | Director | Aug 20, 2020 | Buy | $0.75 | 34,108 | 25,581 | 34,108 | Aug 21, 2020, 04:20 PM |
Sirgo Mark A | Director | Aug 17, 2020 | Buy | $0.56 | 100,000 | 56,000 | 411,784 | Aug 18, 2020, 05:19 PM |
Temperato John | Chief Executive Officer | Aug 17, 2020 | Buy | $0.57 | 35,000 | 19,831 | 545,496 | Aug 17, 2020, 04:18 PM |
Sirgo Mark A | Director | Jun 15, 2020 | Buy | $0.60 | 17,943 | 10,721 | 57,384 | Jun 16, 2020, 04:05 PM |
Temperato John | Chief Executive Officer | Jun 15, 2020 | Buy | $0.60 | 10,000 | 5,971 | 49,441 | Jun 15, 2020, 04:56 PM |
Laumas Sandeep | CEO, Executive Chairman | Jun 28, 2019 | Buy | $1.15 | 4,000 | 4,600 | 18,000 | Jul 01, 2019, 05:00 PM |
Laumas Sandeep | CEO, Executive Chairman | Jun 13, 2019 | Buy | $1.22 | 1,000 | 1,216 | 14,000 | Jun 17, 2019, 08:03 PM |
Madan Jay P. | President | May 30, 2019 | Buy | $1.32 | 5,000 | 6,600 | 84,131 | Jun 03, 2019, 08:00 AM |
Proujansky Roy | Director | May 24, 2019 | Buy | $1.28 | 1,000 | 1,280 | 2,400 | May 28, 2019, 04:30 PM |
Laumas Sandeep | CEO, Executive Chairman | May 22, 2019 | Buy | $1.38 | 5,000 | 6,900 | 13,000 | May 23, 2019, 08:44 AM |
Proujansky Roy | Director | Nov 30, 2018 | Buy | $2.63 | 1,400 | 3,682 | 1,400 | Dec 03, 2018, 07:18 PM |
Laumas Sandeep | Executive Chairman | Nov 30, 2018 | Buy | $2.63 | 3,000 | 7,890 | 8,000 | Dec 03, 2018, 07:16 PM |
Prior Christopher P. | Chief Executive Officer | Nov 29, 2018 | Buy | $2.75 | 5,000 | 13,750 | 7,009 | Nov 29, 2018, 08:00 PM |
Laumas Sandeep | Executive Chairman | Nov 29, 2018 | Buy | $2.56 | 3,000 | 7,670 | 5,000 | Nov 29, 2018, 06:13 PM |
Prior Christopher P. | Chief Executive Officer | Sep 14, 2018 | Buy | $5.82 | 200 | 1,164 | 2,009 | Sep 14, 2018, 06:58 PM |
Prior Christopher P. | Chief Executive Officer | Sep 12, 2018 | Buy | $6.13 | 500 | 3,065 | 1,809 | Sep 13, 2018, 06:00 PM |
Laumas Sandeep | Executive Chairman | Sep 07, 2018 | Buy | $6.10 | 500 | 3,050 | 2,000 | Sep 10, 2018, 05:49 PM |
Laumas Sandeep | Executive Chairman | Aug 30, 2018 | Buy | $5.24 | 500 | 2,620 | 750 | Aug 30, 2018, 08:41 PM |
Prior Christopher P. | Chief Executive Officer | Aug 30, 2018 | Buy | $5.20 | 309 | 1,607 | 1,309 | Aug 30, 2018, 08:39 PM |
Laumas Sandeep | Executive Chairman | Aug 28, 2018 | Buy | $4.90 | 250 | 1,225 | 250 | Aug 30, 2018, 08:38 PM |
Prior Christopher P. | Chief Executive Officer | Aug 28, 2018 | Buy | $4.93 | 1,000 | 4,930 | 1,000 | Aug 28, 2018, 06:19 PM |
Laumas Sandeep | Executive Chairman | Aug 28, 2018 | Buy | $5.01 | 750 | 3,759 | 1,000 | Aug 28, 2018, 06:17 PM |
Almenoff June Sherie | COO and Chief Medical Officer | Aug 27, 2018 | Buy | $4.95 | 400 | 1,979 | 900 | Aug 28, 2018, 04:33 PM |
Almenoff June Sherie | COO and Chief Medical Officer | Aug 24, 2018 | Buy | $4.91 | 1,000 | 4,906 | 1,400 | Aug 28, 2018, 04:33 PM |
CLARKE DAVID H | Former CEO and Director | Nov 29, 2017 | Buy | $0.45 | 366,159 | 164,772 | 1,375,704 | Mar 13, 2018, 10:00 PM |
CLARKE DAVID H | Former CEO and Director | Jun 23, 2017 | Buy | $0.58 | 172,414 | 100,000 | 862,457 | Mar 13, 2018, 10:00 PM |
CLARKE DAVID H | Former CEO and Director | Mar 16, 2017 | Buy | $1.50 | 70,000 | 105,000 | 690,043 | Mar 13, 2018, 10:00 PM |
CLARKE DAVID H | Former CEO and Director | Jul 13, 2016 | Buy | $4.50 | 15,000 | 67,500 | 445,043 | Mar 13, 2018, 10:00 PM |
CLARKE DAVID H | Former CEO and Director | Jan 26, 2018 | Buy | $0.35 | 300,000 | 105,000 | 1,718,450 | Mar 13, 2018, 10:00 PM |
Owner | Relationship | Date | Value($) |
Sensenig Bethany | Chief Financial Officer | 04/21/2023 | 11,011 |
Sirgo Mark A | Director | 07/01/2022 | 42,962 |
Temperato John | Chief Executive Officer | 07/06/2022 | 28,462 |
Sirgo Mark A | Director | 07/01/2022 | 42,962 |
Constantino Michael T. | Director | 05/23/2022 | 7,608 |
Temperato John | Chief Executive Officer | 05/18/2022 | 22,285 |
Sirgo Mark A | Director | 05/18/2022 | 50,000 |
Constantino Michael T. | Director | 08/20/2020 | 20,001 |
Sirgo Mark A | Director | 03/03/2022 | 50,003 |
Temperato John | Chief Executive Officer | 03/03/2022 | 55,590 |
Sirgo Mark A | Director | 12/02/2021 | 44,500 |
Sirgo Mark A | Director | 11/18/2021 | 21,200 |
Temperato John | Chief Executive Officer | 11/18/2021 | 52,500 |
Sitar Edward J | Chief Financial Officer | 09/14/2021 | 18,300 |
Sirgo Mark A | Director | 09/07/2021 | 99,999 |
Constantino Michael T. | Director | 08/24/2021 | 20,520 |
Sirgo Mark A | Director | 08/20/2021 | 27,500 |
Temperato John | Chief Executive Officer | 08/18/2021 | 26,250 |
OrbiMed Israel GP Ltd. | 10% Owner | 06/25/2021 | 19,347,751 |
OrbiMed Israel GP Ltd. | 10% Owner | 06/24/2021 | 440,572 |
OrbiMed Israel GP Ltd. | 10% Owner | 06/23/2021 | 1,144,644 |
Temperato John | Chief Executive Officer | 12/15/2020 | 100,000 |
Sirgo Mark A | Director | 12/15/2020 | 150,000 |
Sitar Edward J | Chief Financial Officer | 12/15/2020 | 40,000 |
Sirgo Mark A | Director | 09/11/2020 | 14,004 |
Sirgo Mark A | Director | 09/11/2020 | 52,360 |
Sirgo Mark A | Director | 09/10/2020 | 30,000 |
Temperato John | Chief Executive Officer | 08/21/2020 | 48,300 |
Constantino Michael T. | Director | 08/20/2020 | 25,581 |
Sirgo Mark A | Director | 08/17/2020 | 56,000 |
Temperato John | Chief Executive Officer | 08/17/2020 | 19,831 |
Sirgo Mark A | Director | 06/15/2020 | 10,721 |
Temperato John | Chief Executive Officer | 06/15/2020 | 5,971 |
Laumas Sandeep | CEO, Executive Chairman | 06/28/2019 | 4,600 |
Laumas Sandeep | CEO, Executive Chairman | 06/13/2019 | 1,216 |
Madan Jay P. | President | 05/30/2019 | 6,600 |
Proujansky Roy | Director | 05/24/2019 | 1,280 |
Laumas Sandeep | CEO, Executive Chairman | 05/22/2019 | 6,900 |
Proujansky Roy | Director | 11/30/2018 | 3,682 |
Laumas Sandeep | Executive Chairman | 11/30/2018 | 7,890 |
Prior Christopher P. | Chief Executive Officer | 11/29/2018 | 13,750 |
Laumas Sandeep | Executive Chairman | 11/29/2018 | 7,670 |
Prior Christopher P. | Chief Executive Officer | 09/14/2018 | 1,164 |
Prior Christopher P. | Chief Executive Officer | 09/12/2018 | 3,065 |
Laumas Sandeep | Executive Chairman | 09/07/2018 | 3,050 |
Laumas Sandeep | Executive Chairman | 08/30/2018 | 2,620 |
Prior Christopher P. | Chief Executive Officer | 08/30/2018 | 1,607 |
Laumas Sandeep | Executive Chairman | 08/28/2018 | 1,225 |
Prior Christopher P. | Chief Executive Officer | 08/28/2018 | 4,930 |
Laumas Sandeep | Executive Chairman | 08/28/2018 | 3,759 |
Almenoff June Sherie | COO and Chief Medical Officer | 08/27/2018 | 1,979 |
Almenoff June Sherie | COO and Chief Medical Officer | 08/24/2018 | 4,906 |
CLARKE DAVID H | Former CEO and Director | 11/29/2017 | 164,772 |
CLARKE DAVID H | Former CEO and Director | 06/23/2017 | 100,000 |
CLARKE DAVID H | Former CEO and Director | 03/16/2017 | 105,000 |
CLARKE DAVID H | Former CEO and Director | 07/13/2016 | 67,500 |
CLARKE DAVID H | Former CEO and Director | 01/26/2018 | 105,000 |
Period of Report: 12/31/2022
10-K/10-Q Filings: View